✦ LIBER ✦

Inhibition of platelet-derived growth factor receptor tyrosine kinase by atrial natriuretic peptide

✍ Scribed by Awazu, Midori

Book ID: 109884892
Publisher: Nature Publishing Group
Year: 1997
Tongue: English
Weight: 631 KB
Volume: 52
Category: Article
ISSN: 0085-2538
DOI: 10.1038/ki.1997.341

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Rapid Bioassay for Platelet–Derived Gr

A Rapid Bioassay for Platelet–Derived Growth Factor β-Receptor Tyrosine Kinase Function

✍ Graminski, Gerard F.; Lerner, Michael R. 📂 Article 📅 1994 🏛 Springer Science and Business Media LLC 🌐 English ⚖ 571 KB

Specific inhibition of epidermal growth

Specific inhibition of epidermal growth factor receptor tyrosine kinase by 4-anilinoquinazolines

✍ A. E. Wakeling; A. J. Barker; D. H. Davies; D. S. Brown; L. R. Green; S. A. Cart 📂 Article 📅 1996 🏛 Springer US 🌐 English ⚖ 506 KB

Inhibition of choroidal neovascularizati

Inhibition of choroidal neovascularization by blocking vascular endothelial growth factor receptor tyrosine kinase

✍ Junko Kami; Kimimasa Muranaka; Yasuo Yanagi; Ryo Obata; Yasuhiro Tamaki; Masabum 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 279 KB

Stimulation of tyrosine-specific phospho

Stimulation of tyrosine-specific phosphorylation by platelet-derived growth factor

✍ Ek, Bo; Westermark, Bengt; Wasteson, Åke; Heldin, Carl-Henrik 📂 Article 📅 1982 🏛 Nature Publishing Group 🌐 English ⚖ 305 KB

Platelet-derived growth factor receptor

Platelet-derived growth factor receptor independent proliferation of human glioblastoma cells: selective tyrosine kinase inhibitors lack antiproliferative activity

✍ Dietmar Gross; Günther Bernhardt; Armin Buschauer 📂 Article 📅 2006 🏛 Springer-Verlag 🌐 English ⚖ 594 KB

Enantioselective inhibition of the epide

Enantioselective inhibition of the epidermal growth factor receptor tyrosine kinase by 4-(α-phenethylamino)quinazolines

✍ Alexander J. Bridges; Donna R. Cody; Hairong Zhou; Amy McMichael; David W. Fry 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 523 KB

4-Benzylaminoquinazolines can be potent reversible inhibitors of the EGFR tyrosine kinase at the ATP binding site. Examination of benzylic methylation reveals that an (R)-methyl group is four- to six-fold activating, with an optimal Ki of 630 pM for compound 11. In sharp contrast, (S)-methylation ca